195 related articles for article (PubMed ID: 7261952)
1. Penbutolol: a preliminary review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.
Heel RC; Brogden RN; Speight TM; Avery GS
Drugs; 1981 Jul; 22(1):1-25. PubMed ID: 7261952
[TBL] [Abstract][Full Text] [Related]
2. Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectoris.
Silke B; Nelson GI; Verma SP; Ahuja RC; Okoli RC; Hussain M; Taylor SH
Herz; 1984 Feb; 9(1):57-64. PubMed ID: 6368345
[TBL] [Abstract][Full Text] [Related]
3. Penbutolol: a new beta-adrenergic blocking agent.
Schlanz KD; Thomas RL
DICP; 1990 Apr; 24(4):403-8. PubMed ID: 2183495
[TBL] [Abstract][Full Text] [Related]
4. Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.
Heel RC; Brogden RN; Pakes GE; Speight TM; Avery GS
Drugs; 1980 Jul; 20(1):1-23. PubMed ID: 6105067
[TBL] [Abstract][Full Text] [Related]
5. Celiprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris.
Riddell JG; Shanks RG; Brogden RN
Drugs; 1987 Oct; 34(4):438-58. PubMed ID: 2890513
[TBL] [Abstract][Full Text] [Related]
6. Haemodynamic dose-response effects of i.v. penbutolol in angina pectoris.
Silke B; Verma SP; Hussain M; Nelson GI; Okoli RC; Taylor SH
Br J Clin Pharmacol; 1983 Nov; 16(5):529-35. PubMed ID: 6315039
[TBL] [Abstract][Full Text] [Related]
7. Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonism.
Frishman WH; Covey S
J Clin Pharmacol; 1990 May; 30(5):412-21. PubMed ID: 2189902
[TBL] [Abstract][Full Text] [Related]
8. Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.
Heel RC; Brogden RN; Speight TM; Avery GS
Drugs; 1979 Jun; 17(6):425-60. PubMed ID: 38096
[TBL] [Abstract][Full Text] [Related]
9. Single daily dose penbutolol in the treatment of hypertension: a double blind crossover comparison with propranolol.
Kubik MM; Hanks GW
Eur J Clin Pharmacol; 1980 Jun; 17(6):409-13. PubMed ID: 6995132
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of the effects of penbutolol and propranolol in the treatment of angina pectoris.
Hillis WS; Tweddel AC; Murray RG; Lawrie TD
Arzneimittelforschung; 1980; 30(9):1595-9. PubMed ID: 7006619
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of once daily penbutolol in chronic stable angina. An objective comparison with long-acting propranolol.
Bowles MJ; Khurmi NS; Bala Subramanian V; Raftery EB
Int J Cardiol; 1984 Feb; 5(2):131-42. PubMed ID: 6365803
[TBL] [Abstract][Full Text] [Related]
12. Bevantolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris.
Frishman WH; Goldberg RJ; Benfield P
Drugs; 1988 Jan; 35(1):1-21. PubMed ID: 2894292
[TBL] [Abstract][Full Text] [Related]
13. [Effectiveness of a new beta adrenergic blocking agent (penbutolol) in the treatment of ischemic cardiopathy].
Ortuño Aznar F; Martín Jadraque L
Med Clin (Barc); 1985 May; 84(19):766-8. PubMed ID: 2863437
[No Abstract] [Full Text] [Related]
14. Comparison of the effects of penbutolol and propranolol on glomerular filtration rate in hypertensive patients with impaired renal function.
van der Meulen J; Reijn E; Heidendal GA; Oe PL; Donker AJ
Br J Clin Pharmacol; 1986 Oct; 22(4):469-74. PubMed ID: 3533129
[TBL] [Abstract][Full Text] [Related]
15. Double-blind comparison of prenylamine and penbutolol in patients with angina pectoris.
Slegers LC; Vermeulen A; Sumajow CA
J Int Med Res; 1985; 13(4):229-35. PubMed ID: 3899772
[TBL] [Abstract][Full Text] [Related]
16. Use of fixed doses of beta blocking drugs in the treatment of hypertension. Randomised study of atenolol and penbutolol.
Lameijer LD; Voermans LA; Houtzagers JJ; Chadha DR
Eur J Clin Pharmacol; 1981; 21(2):93-6. PubMed ID: 7042370
[TBL] [Abstract][Full Text] [Related]
17. Bisoprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris.
Lancaster SG; Sorkin EM
Drugs; 1988 Sep; 36(3):256-85. PubMed ID: 2903820
[TBL] [Abstract][Full Text] [Related]
18. Penbutolol: comparison of its antihypertensive effect with that of alpha-methyldopa in patients with primary hypertension.
Vierhapper H; Dudczak R; Waldhäusl W
Arzneimittelforschung; 1980; 30(6):1008-11. PubMed ID: 7191259
[TBL] [Abstract][Full Text] [Related]
19. [On the pharmacology of the beta-receptor blocker penbutolol (author's transl)].
Kaiser J; Härtfelder G; Lindner E; Schölkens B
Arzneimittelforschung; 1980; 30(3):420-7. PubMed ID: 6992788
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic and pharmacokinetic study of oral and intravenous penbutolol.
Vedin JA; Wilhelmsson C; Maass L; Peterson LE
Eur J Clin Pharmacol; 1983; 25(4):529-34. PubMed ID: 6653649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
